Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection
Rom S. Leidner(Providence Portland Medical Center), Marka R. Crittenden(Providence Portland Medical Center), Shorin Nemeth(Providence Portland Medical Center), Marcus Couey(Providence Portland Medical Center), Dawn Brucker(Providence Portland Medical Center), Brendan D. Curti(Providence Portland Medical Center), Lessli Rushforth(Providence Portland Medical Center), Amber L. Watters(Providence Portland Medical Center), Michael J. Gough(Providence Portland Medical Center), Kristina H. Young(Providence Portland Medical Center), Carlo Bifulco(Providence Health & Services), Brian Piening(Providence College), Ashish Patel(King's College London), Hong Xiao(Providence Portland Medical Center), George Morris(Providence Portland Medical Center), R. Bryan Bell(Providence Portland Medical Center)
Cited by 1
Related Papers
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620